BetterLife Pharma Inc. (BETR.CN)
CAD 0.1
(5.56%)
CAD 0.1
(5.56%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -0.03 CAD | 73.6% |
| 2022 | -0.10 CAD | 37.5% |
| 2021 | -0.16 CAD | 88.06% |
| 2020 | -1.34 CAD | -3.08% |
| 2019 | -1.30 CAD | -26.21% |
| 2018 | -1.03 CAD | -5408.02% |
| 2017 | -0.02 CAD | 98.28% |
| 2016 | -1.09 CAD | 29.22% |
| 2015 | -1.54 CAD | -79.07% |
| 2014 | -0.86 CAD | -437.5% |
| 2013 | -0.16 CAD | -267.54% |
| 2012 | 0.10 CAD | -77.26% |
| 2011 | 0.42 CAD | 138.89% |
| 2010 | -1.08 CAD | -2038.61% |
| 2009 | -0.05 CAD | 83.17% |
| 2008 | -0.30 CAD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | -0.02 CAD | -50.0% |
| 2024 Q2 | -0.01 CAD | 28.57% |
| 2023 Q3 | -0.00 CAD | 81.72% |
| 2023 Q2 | -0.01 CAD | 3.13% |
| 2023 Q1 | -0.01 CAD | -284.0% |
| 2023 Q4 | -0.01 CAD | -558.82% |
| 2023 FY | - CAD | 73.6% |
| 2022 Q4 | -0.00 CAD | 95.4% |
| 2022 Q1 | -0.04 CAD | 24.24% |
| 2022 Q2 | -0.01 CAD | 62.57% |
| 2022 Q3 | -0.05 CAD | -315.27% |
| 2022 FY | - CAD | 37.5% |
| 2021 Q2 | -0.05 CAD | -3.79% |
| 2021 FY | - CAD | 88.06% |
| 2021 Q1 | -0.04 CAD | 91.04% |
| 2021 Q3 | -0.03 CAD | 44.09% |
| 2021 Q4 | -0.05 CAD | -77.69% |
| 2020 Q2 | -0.09 CAD | -2484.21% |
| 2020 Q1 | 0.00 CAD | 100.61% |
| 2020 Q4 | -0.50 CAD | -100.0% |
| 2020 FY | - CAD | -3.08% |
| 2020 Q3 | -0.25 CAD | -175.94% |
| 2019 FY | - CAD | -26.21% |
| 2019 Q1 | -0.19 CAD | -151.99% |
| 2019 Q4 | -0.62 CAD | -313.33% |
| 2019 Q3 | -0.15 CAD | 46.43% |
| 2019 Q2 | -0.28 CAD | -47.37% |
| 2018 Q2 | -0.22 CAD | 8.33% |
| 2018 Q1 | -0.24 CAD | -401.04% |
| 2018 Q4 | -0.08 CAD | 84.61% |
| 2018 Q3 | -0.49 CAD | -122.73% |
| 2018 FY | - CAD | -5408.02% |
| 2017 Q1 | -0.06 CAD | 51.92% |
| 2017 FY | - CAD | 98.28% |
| 2017 Q4 | -0.05 CAD | -136.85% |
| 2017 Q3 | 0.13 CAD | 14544.44% |
| 2017 Q2 | -0.00 CAD | 98.44% |
| 2016 Q2 | -0.20 CAD | 64.29% |
| 2016 Q3 | -0.17 CAD | 15.0% |
| 2016 FY | - CAD | 29.22% |
| 2016 Q4 | -0.12 CAD | 29.41% |
| 2016 Q1 | -0.56 CAD | 45.1% |
| 2015 Q4 | -1.02 CAD | -84900.0% |
| 2015 FY | - CAD | -79.07% |
| 2015 Q2 | -0.37 CAD | -85.0% |
| 2015 Q1 | -0.20 CAD | -66.67% |
| 2015 Q3 | -0.00 CAD | 99.68% |
| 2014 Q2 | -0.03 CAD | -131.5% |
| 2014 Q1 | 0.10 CAD | 1951.85% |
| 2014 FY | - CAD | -437.5% |
| 2014 Q4 | -0.12 CAD | 14.29% |
| 2014 Q3 | -0.14 CAD | -344.44% |
| 2013 Q4 | -0.01 CAD | 95.5% |
| 2013 Q2 | -0.01 CAD | 1.46% |
| 2013 Q3 | -0.12 CAD | -788.89% |
| 2013 Q1 | -0.01 CAD | 29.02% |
| 2013 FY | - CAD | -267.54% |
| 2012 Q4 | -0.02 CAD | -13.53% |
| 2012 FY | - CAD | -77.26% |
| 2012 Q1 | 0.20 CAD | 174.07% |
| 2012 Q2 | -0.03 CAD | -117.2% |
| 2012 Q3 | -0.02 CAD | 50.58% |
| 2011 Q1 | 0.60 CAD | 165.93% |
| 2011 Q3 | 0.04 CAD | -7.09% |
| 2011 Q4 | -0.27 CAD | -835.69% |
| 2011 FY | - CAD | 138.89% |
| 2011 Q2 | 0.04 CAD | -93.42% |
| 2010 Q2 | -0.02 CAD | -56.64% |
| 2010 Q1 | -0.01 CAD | -56.94% |
| 2010 Q4 | -0.91 CAD | -14344.44% |
| 2010 FY | - CAD | -2038.61% |
| 2010 Q3 | -0.01 CAD | 64.41% |
| 2009 Q2 | -0.03 CAD | -492.59% |
| 2009 Q3 | -0.01 CAD | 81.56% |
| 2009 FY | - CAD | 83.17% |
| 2009 Q4 | -0.01 CAD | -22.03% |
| 2009 Q1 | -0.01 CAD | 0.0% |
| 2008 FY | - CAD | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Algernon Pharmaceuticals Inc. | -0.45 CAD | 94.133% |
| Asep Medical Holdings Inc | -0.13 CAD | 79.692% |
| BioVaxys Technology Corp. | -0.06 CAD | 53.927% |
| ChitogenX Inc. | -0.02 CAD | -23.944% |
| Rapid Dose Therapeutics Corp. | -0.04 CAD | 35.61% |
| Defence Therapeutics Inc. | -0.30 CAD | 91.2% |
| Entheon Biomedical Corp. | -0.05 CAD | 48.031% |
| Gemina Laboratories Ltd. | -0.07 CAD | 63.333% |
| Glow Lifetech Corp. | -0.03 CAD | 8.333% |
| Lexston Life Sciences Corp. | -0.02 CAD | -14.783% |
| Pharmala Biotech Holdings Inc. | -0.01 CAD | -186.957% |
| Doseology Sciences Inc. | -0.08 CAD | 66.876% |
| MYND Life Sciences Inc. | -0.03 CAD | 17.757% |
| Nova Mentis Life Science Corp. | -0.01 CAD | -218.072% |
| PharmaTher Holdings Ltd. | -0.04 CAD | 25.212% |
| PreveCeutical Medical Inc. | -0.00 CAD | -1000.0% |
| Telescope Innovations Corp. | -0.12 CAD | 78.0% |